---
figid: PMC11201226__biomedicines-12-01140-g003
pmcid: PMC11201226
image_filename: PMC11201226__biomedicines-12-01140-g003.jpg
figure_link: /pmc/articles/PMC11201226/figure/F3/
number: Figure 3
figure_title: Proteomic differential analysis at the onset of irAEs.
caption: 'Proteomic differential analysis at the onset of irAEs. (a) Volcano plot
  of plasma differential proteins at the onset of irAEs. (b) Temporal trends of differential
  markers during irAEs. (c) KEGG pathway enrichment analysis of differential plasma
  proteins in patients at the onset of irAEs. ****: ≤0.0001; ***: ≤0.001; *: ≤0.05'
article_title: Activation of CD14+ Monocytes via the IFN-γ Signaling Pathway Is Associated
  with Immune-Related Adverse Events in Hepatocellular Carcinoma Patients Receiving
  PD-1 Inhibition Combination Therapy
citation: Yaoru Song, et al. Biomedicines. 2024 Jun;12(6).
year: '2024'
pub_date: 2024-6-
epub_date: 2024-5-21
doi: 10.3390/biomedicines12061140
journal_title: Biomedicines
journa_nlm_ta: Biomedicines
publisher_name: MDPI
keywords:
- hepatocellular carcinoma
- immune-related adverse events
- checkpoint inhibitor
- monocytes
- IFN-γ signaling
---
